Exploratory research into the effect of temporarily withdrawal of PPIs (Proton Pump Inhibitor) use, to reduce the stomach wall uptake of 99mTc-Sestamibi in a myocardial perfusion imaging - The effect of shortterm withdrawal of PPI for myocardial perfusion imaging.

Rijnstate Ziekenhuis0 个研究点目标入组 60 人开始时间: 待定最近更新: 2024年4月23日

适应症

试验速览

暂无简介。

•- Patients with a cardiology reference indication for myocardial perfusion imaging.
•- Patients older than 18 years.
•- Patients wherein for the myocardial perfusion preformed with etheir adenosine or regadenoson
•- Patients taking preventive less than 90 days using PPIs
•- Patients who have signed an informed consent.
•- Patients in which the scan was performed on the scanner BrightView 1 in Nucleare department Rijnstate Arnhem.
•- Patients who have no defects at the myocardal inferiorwall.

•- Patients with dyspepsia
•- Patients with only uptake in the stomach cavity, thus no reliable measurement can be done and no visually assesment can be reliable preformed.
•- Patients who are not prepared and tested according to the protocols
•- Patients with the following well-known diseases, Zollinger Ellison Syndrome, a barrettoesofagus or a esophagitis with endoscopic grade C or D
•- Patients partially been injectjet or underskin injection, no maximum uptake of radiopharmaceutical is can be reached.
•- Patients that use medications that interact with PPIs.
•- Patients with gastric resection or surgically treated for stomach problems.
•- Patients with gastric ulcer prophylaxis.

发起方

Rijnstate Ziekenhuis